This stock could soar as cannabis beverage sales hit $2.5 billion
A popular Seattle cannabis manufacturer is now partnering with other companies to produce a new line of cannabis-infused beverages. It’s perfect timing. A new report reveals cannabis beverage sales will reach $2.8 billion by 2025, expanding at an annual compounded rate of 17.8%. A huge opportunity!
Find out why this could be the #1 penny stock

TLT Insider Trading (Theralase Technologies)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): C$106,419.86
Insider Selling (Last 12 Months): C$0.00

Theralase Technologies Insider Trading History Chart

This chart shows the insider buying and selling history at Theralase Technologies by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Theralase Technologies Share Price & Price History

Current Price: C$0.25
Price Change: +0.30 (1.20%)
As of 07/30/2021 04:38 PM ET

This chart shows the closing price history over time for TLT up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Your 15 Minute Workday… (Make Extra Cash from Home)
Some people binge watch Netflix… Hulu…or HBO shows. And some people turn their downtime into cash. James made $2,275 in just 19 minutes…all thanks to something called The 15 Minute Workday. The average trade makes 12% in just 5 days (factoring winners and losers) which is out of this world.
Click here to start

Theralase Technologies Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/4/2021Roger John Dumoulin-WhiteDirectorBuy50,000C$0.21C$10,500.007,396,087
5/3/2021Kristina Maria HacheySenior OfficerBuy90,000C$0.22C$19,800.001,706,267
4/30/2021Arkady MandelSenior OfficerBuy60,000C$0.24C$14,100.0060,000
4/19/2021Roger John Dumoulin-WhiteDirectorBuy65,500C$0.25C$16,375.007,341,587
2/25/2021Roger John Dumoulin-WhiteDirectorBuy10,000C$0.28C$2,800.007,276,087
2/17/2021Roger John Dumoulin-WhiteDirectorBuy30,500C$0.25C$7,625.007,266,087
1/28/2021Roger John Dumoulin-WhiteDirectorBuy45,500C$0.22C$10,010.007,235,587
1/18/2021Guy John AndersonDirectorBuy27,777C$0.18C$4,999.86213,777
9/25/2020Roger John Dumoulin-WhiteDirectorBuy33,000C$0.16C$5,280.007,190,087
9/15/2020Roger John Dumoulin-WhiteDirectorBuy29,000C$0.17C$4,930.007,157,087
7/31/2020Roger John Dumoulin-WhiteDirectorBuy62,500C$0.16C$10,000.007,128,087
7/22/2020Roger John Dumoulin-WhiteDirectorBuy48,000C$0.21C$10,080.007,065,587
6/15/2020Roger John Dumoulin-WhiteDirectorBuy43,500C$0.23C$10,005.007,017,587
6/2/2020Roger John Dumoulin-WhiteDirectorBuy40,000C$0.25C$10,000.006,974,087
5/1/2020Roger John Dumoulin-WhiteDirectorBuy48,000C$0.21C$10,080.006,934,087
4/22/2020Roger John Dumoulin-WhiteDirectorBuy60,000C$0.18C$10,500.006,886,087
4/8/2020Roger John Dumoulin-WhiteDirectorBuy45,400C$0.22C$9,988.006,826,087
4/1/2020Roger John Dumoulin-WhiteDirectorBuy2,500C$0.18C$450.006,780,687
3/17/2020Roger John Dumoulin-WhiteDirectorBuy53,000C$0.19C$10,070.006,778,187
2/18/2020Roger John Dumoulin-WhiteDirectorBuy38,500C$0.26C$10,010.006,725,187
1/28/2020Roger John Dumoulin-WhiteDirectorBuy34,000C$0.30C$10,030.006,686,687
12/19/2019Roger John Dumoulin-WhiteDirectorBuy32,500C$0.32C$10,400.006,652,687
11/19/2019Roger John Dumoulin-WhiteDirectorBuy45,000C$0.23C$10,125.006,620,187
10/18/2019Roger John Dumoulin-WhiteDirectorBuy45,000C$0.21C$9,450.006,575,187
See Full Table
Insider Trading at Theralase Technologies?
Sign-up to receive's daily insider buying and selling report for Theralase Technologies and related companies.

SEC Filings (Institutional Ownership Changes) for Theralase Technologies (CVE:TLT)

Theralase Technologies Inc., a clinical stage pharmaceutical company, engages in the research and development of photo dynamic compounds (PDCs) and their associated drug formulations to treat cancer in Canada, the United States, and internationally. The company also designs, develops, manufactures, and commercializes medical laser systems and other technologies for the activation of PDCs; designs, develops, manufactures, and markets patented and proprietary super-pulsed laser technology for the healing of chronic knee pain, as well as for off-label use to heal various nerve, muscle, and joint conditions. The company is developing TLD-1433, which is in Phase II for the treatment of non-muscle invasive bladder cancer (NMIBC). Its products include TLC-1000, TLC-2000, and controllerless series laser technology products for the elimination of pain, reduction of inflammation, and acceleration of tissue healing, as well as TLC-1000 and TLC-2000 accessories; and Theralase therapeutic laser treatments for patients, including pain management, arthritis, wound healing, addiction rehabilitation and weight loss, and anti-aging, as well as companion animals and equine. Theralase Technologies Inc. has research agreements with the University of Manitoba Medical Microbiology department for the development of a coronavirus vaccine and therapy; and the National Microbiolog Laboratory and Public Health Agency of Canada for the research and development of a Canadian-based SARS-CoV-2 vaccine. The company sells its products to healthcare practitioners. Theralase Technologies Inc. was founded in 1994 and is headquartered in Toronto, Canada.
Read More on Theralase Technologies

Today's Range

Now: C$0.25
Low: C$0.24
High: C$0.25

50 Day Range

MA: C$0.25
Low: C$0.22
High: C$0.28

52 Week Range

Now: C$0.25
Low: C$0.12
High: C$0.32


55,500 shs

Average Volume

265,881 shs

Market Capitalization

C$50.05 million

P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of Theralase Technologies?

Theralase Technologies' top insider shareholders include:
  1. Roger John Dumoulin-White (Director)
  2. Kristina Maria Hachey (Senior Officer)
  3. Guy John Anderson (Director)
  4. Arkady Mandel (Senior Officer)
10 Million People Started Trading Last Year – Here’s What to Do Next
How do you make money trading?
What are the secrets pros use to beat the market day after day?
Former Chicago Board Options Exchange trader reveals all the insider tricks...
Get the Full Report Now (No Credit Card Required... Limited Time Only)